ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Jay Luly on Q1 2022 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2022 Earnings Conference Call February 08, 2022, 04:30 PM ET Company Participants Jennifer Viera - IR Jay Luly - President and CEO Paul Mellett - CFO Nathalie Adda - Chief Medical Officer Conference Call Participants Brian Abrahams - RBC Capital Markets Yasmeen Rahimi - Piper Sandler Roy Buchanan - JMP Securities Zegbeh Jallah - ROTH Capital Jay Olson - Oppenheimer Brian Skorney - Baird Roanna Ruiz - SVB Leerink Liisa Bayko - Evercore ISI Presentation Operator Good afternoon and welcome to the Enanta Pharmaceuticals Fiscal First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of the prepared remarks. Please be advised that this call is being recorded. I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead. Jennifer Viera Thank you,
For further details see:
Enanta Pharmaceuticals, Inc. (ENTA) CEO Jay Luly on Q1 2022 Results - Earnings Call Transcript